Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report.

This report has been ready by the European Academy of Allergy and Clinical Immunology Task Force on Allergic Rhinitis (AR) comorbidities. The goal of this multidisciplinary European consensus doc is to spotlight the function of multimorbidities in the definition, classification, mechanisms, suggestions for prognosis and remedy of AR, and to outline the wants in this uncared for space by a literature overview.

AR is a systemic allergic illness and is mostly related to quite a few multi-morbid problems, together with bronchial asthma, eczema, meals allergic reactions, eosinophilic oesophagitis (EoE), conjunctivitis, power center ear effusions, rhinosinusitis, adenoid hypertrophy, olfaction problems, obstructive sleep apnea, disordered sleep and consequent behavioural and instructional results.

This report supplies up-to-date usable data to: (1) enhance the data and expertise of allergists, in order to in the end enhance the general high quality of affected person care; (2) to extend curiosity in this space; and (3) to current a singular contribution to the sphere of higher inflammatory illness.

 Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report.
Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report.

A piece group report on ultrafine particles (American Academy of Allergy, Asthma & Immunology): Why ambient ultrafine and engineered nanoparticles ought to obtain particular consideration for doable hostile well being outcomes in human topics.

Ultrafine particles (UFPs) are airborne particulates of lower than 100 nm in aerodynamic diameter. Examples of UFPs are diesel exhaust particles, merchandise of cooking, heating, and wooden burning in indoor environments, and, extra not too long ago, merchandise generated by the use of nanotechnology. Studies have proven that ambient UFPs have detrimental results on each the cardiovascular and respiratory techniques, together with the next incidence of atherosclerosis and exacerbation fee of bronchial asthma.

HighQC™ Human Cord Blood-CD34+ Hematopoietic Stem Cell

ABC-SC0085T 1 vial Ask for price
Description: Desired cells are isolated using positive magnetic isolation of CD34 from cord blood. CD34+ cells are targeted using uniform, superparamagnetic polymer beads coated with a primary monoclonal antibody specific for the CD34 membrane antigen predominantly expressed on human hematopoietic progenitor cells and endothelial progenitor cells. The isolated cells are poured off into a new tube, and are cryogenically preserved.

CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), 0.2mg/mL

BNUB1807-100 1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), 0.2mg/mL

BNUB1807-500 1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), 1mg/mL

BNUM1807-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Human Uncharacterized hematopoietic stem/progenitor cells protein MDS032 / MDS032 (USE1) ELISA Kit

abx384157-96tests 96 tests
EUR 1093.2

Human Uncharacterized hematopoietic stem/progenitor cells protein MDS032 / MDS032 (USE1) ELISA Kit

abx384157-1096tests 10 × 96 tests Ask for price

Human Uncharacterized hematopoietic stem/progenitor cells protein MDS032 / MDS032 (USE1) ELISA Kit

abx384157-596tests 5 × 96 tests Ask for price

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), 0.2mg/mL

BNUB2184-100 1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), 0.2mg/mL

BNUB2184-500 1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), 0.2mg/mL

BNUB2185-100 100uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), 0.2mg/mL

BNUB2185-500 500uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), 0.2mg/mL

BNUB2598-100 100uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), 0.2mg/mL

BNUB2598-500 500uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), 1mg/mL

BNUM2184-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), 1mg/mL

BNUM2185-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), 1mg/mL

BNUM2598-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody

BNUB2185-50 50uL
EUR 486
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), 1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody

BNUB2598-50 50uL
EUR 486
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), 1mg/mL

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody

BNC702185-100 100uL
EUR 279.6
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF770 conjugate, Concentration: 0.1mg/mL

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody

BNC702185-500 500uL
EUR 654
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF770 conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody

BNC702598-100 100uL
EUR 279.6
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF770 conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody

BNC702598-500 500uL
EUR 654
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF770 conjugate, Concentration: 0.1mg/mL

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody

BNC802185-100 100uL
EUR 279.6
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF680 conjugate, Concentration: 0.1mg/mL

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody

BNC802185-500 500uL
EUR 654
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF680 conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody

BNC802598-100 100uL
EUR 279.6
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF680 conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody

BNC802598-500 500uL
EUR 654
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF680 conjugate, Concentration: 0.1mg/mL

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody

BNC812185-100 100uL
EUR 279.6
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF680R conjugate, Concentration: 0.1mg/mL

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody

BNC812185-500 500uL
EUR 654
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF680R conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody

BNC812598-100 100uL
EUR 279.6
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF680R conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody

BNC812598-500 500uL
EUR 654
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF680R conjugate, Concentration: 0.1mg/mL

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody

BNC552185-100 100uL
EUR 279.6
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF555 conjugate, Concentration: 0.1mg/mL

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody

BNC552185-500 500uL
EUR 654
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF555 conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody

BNC552598-100 100uL
EUR 279.6
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF555 conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody

BNC552598-500 500uL
EUR 654
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF555 conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody

BNC432598-100 100uL
EUR 279.6
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF543 conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody

BNC432598-500 500uL
EUR 654
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF543 conjugate, Concentration: 0.1mg/mL

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody

BNC612185-100 100uL
EUR 279.6
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF660R conjugate, Concentration: 0.1mg/mL

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody

BNC612185-500 500uL
EUR 654
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF660R conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody

BNC612598-100 100uL
EUR 279.6
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF660R conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody

BNC612598-500 500uL
EUR 654
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF660R conjugate, Concentration: 0.1mg/mL

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody

BNC432185-100 100uL
EUR 279.6
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF543 conjugate, Concentration: 0.1mg/mL

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody

BNC432185-500 500uL
EUR 654
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF543 conjugate, Concentration: 0.1mg/mL

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody

BNC052185-100 100uL
EUR 279.6
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF405M conjugate, Concentration: 0.1mg/mL

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody

BNC052185-500 500uL
EUR 654
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF405M conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody

BNC052598-100 100uL
EUR 279.6
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF405M conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody

BNC052598-500 500uL
EUR 654
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF405M conjugate, Concentration: 0.1mg/mL

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody

BNCA2185-250 250uL
EUR 472.8
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), APC conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody

BNCA2598-250 250uL
EUR 472.8
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), APC conjugate, Concentration: 0.1mg/mL

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody

BNCAP2185-100 100uL
EUR 279.6
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody

BNCAP2185-500 500uL
EUR 654
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody

BNCAP2598-100 100uL
EUR 279.6
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody

BNCAP2598-500 500uL
EUR 654
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody

BNCH2185-100 100uL
EUR 279.6
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody

BNCH2185-500 500uL
EUR 654
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody

BNCH2598-100 100uL
EUR 279.6
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody

BNCH2598-500 500uL
EUR 654
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody

BNCP2185-250 250uL
EUR 472.8
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), PerCP conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody

BNCP2598-250 250uL
EUR 472.8
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), PerCP conjugate, Concentration: 0.1mg/mL

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185) Antibody

BNCR2185-250 250uL
EUR 472.8
Description: Primary antibody against Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), RPE conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R) Antibody

BNCR2598-250 250uL
EUR 472.8
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), RPE conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R), 0.2mg/mL

BNUB1806-100 100uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R), 0.2mg/mL

BNUB1806-500 500uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R), 1mg/mL

BNUM1806-50 50uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody

BNC701806-100 100uL
EUR 238.8
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF770 conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody

BNC701806-500 500uL
EUR 652.8
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF770 conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody

BNC801806-100 100uL
EUR 238.8
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF680 conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody

BNC801806-500 500uL
EUR 652.8
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF680 conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody

BNC811806-100 100uL
EUR 238.8
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF680R conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody

BNC811806-500 500uL
EUR 652.8
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF680R conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody

BNC551806-100 100uL
EUR 238.8
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF555 conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody

BNC551806-500 500uL
EUR 652.8
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF555 conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody

BNC611806-100 100uL
EUR 238.8
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF660R conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody

BNC611806-500 500uL
EUR 652.8
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF660R conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody

BNC431806-100 100uL
EUR 238.8
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF543 conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody

BNC431806-500 500uL
EUR 652.8
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF543 conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody

BNC051806-100 100uL
EUR 238.8
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF405M conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody

BNC051806-500 500uL
EUR 652.8
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),CF405M conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody

BNCA1806-250 250uL
EUR 459.6
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),APC conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody

BNCAP1806-100 100uL
EUR 238.8
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody

BNCAP1806-500 500uL
EUR 652.8
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody

BNCH1806-100 100uL
EUR 238.8
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody

BNCH1806-500 500uL
EUR 652.8
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody

BNCP1806-250 250uL
EUR 459.6
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),PerCP conjugate, Concentration: 0.1mg/mL

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R) Antibody

BNCR1806-250 250uL
EUR 459.6
Description: Primary antibody against CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/1806R),RPE conjugate, Concentration: 0.1mg/mL

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker); Clone 3D3 (Concentrate)

RA0264-C.1 0.1 ml
EUR 60.07

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker); Clone 3D3 (Concentrate)

RA0264-C.5 0.5 ml
EUR 200.66

anti-CD34 Hematopoietic precursor cells

513-A 1 MG
EUR 850

anti-CD34 Hematopoietic precursor cells

513-A-01mg 0,1 mg
EUR 321
Description: anti-CD34 Hematopoietic precursor cells

anti-CD34 Hematopoietic precursor cells

513-A-1000ug 1000 ug
EUR 1539
Description: anti-CD34 Hematopoietic precursor cells

anti-CD34 Hematopoietic precursor cells

513-A-100ugvial 100 ug/vial
EUR 150
Description: anti-CD34 Hematopoietic precursor cells

CD34 (Hematopoietic Stem Cell & Endothelial Marker); Clone QBEnd/10 (Concentrate)

RA0052-C.1 0.1 ml
EUR 60.07

CD34 (Hematopoietic Stem Cell & Endothelial Marker); Clone QBEnd/10 (Concentrate)

RA0052-C.5 0.5 ml
EUR 200.66

CD34 (Hematopoietic Stem Cell & Endothelial Marker); Clone HPCA1/763 (Concentrate)

RA0053-C.1 0.1 ml
EUR 60.07

CD34 (Hematopoietic Stem Cell & Endothelial Marker); Clone HPCA1/763 (Concentrate)

RA0053-C.5 0.5 ml
EUR 200.66

Anti-Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) Monoclonal Antibody

M03359 100ug/vial
EUR 476.4
Description: Mouse Monoclonal Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) Antibody. Validated in Flow Cytometry, IP and tested in Human, Rabbit, Rat.

CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), CF568 conjugate, 0.1mg/mL

BNC681807-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), CF568 conjugate, 0.1mg/mL

BNC681807-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), CF647 conjugate, 0.1mg/mL

BNC471807-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), CF647 conjugate, 0.1mg/mL

BNC471807-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), CF594 conjugate, 0.1mg/mL

BNC941807-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), CF594 conjugate, 0.1mg/mL

BNC941807-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Monoclonal Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) Antibody, Clone: 3D3

AMM01202G 7 ml
EUR 580.8
Description: A Monoclonal antibody against Human Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker). The antibodies are raised in Mouse and are from clone 3D3. This antibody is applicable in WB, IHC and IF, FC, IP

Monoclonal Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) Antibody, Clone: 2A4

AMM01205G 7 ml
EUR 580.8
Description: A Monoclonal antibody against Human Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker). The antibodies are raised in Mouse and are from clone 2A4. This antibody is applicable in IHC, IF, FC

CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), CF488A conjugate, 0.1mg/mL

BNC881807-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), CF488A conjugate, 0.1mg/mL

BNC881807-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), CF405S conjugate, 0.1mg/mL

BNC041807-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), CF405S conjugate, 0.1mg/mL

BNC041807-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), CF640R conjugate, 0.1mg/mL

BNC401807-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), CF640R conjugate, 0.1mg/mL

BNC401807-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), Biotin conjugate, 0.1mg/mL

BNCB1807-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker)(N/A), Biotin conjugate, 0.1mg/mL

BNCB1807-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Monoclonal CD34 (Hematopoietic Stem Cell & Endothelial Marker) Antibody, Clone: SPM123

AMM01547G 7 ml
EUR 580.8
Description: A Monoclonal antibody against Human CD34 (Hematopoietic Stem Cell & Endothelial Marker). The antibodies are raised in Mouse and are from clone SPM123. This antibody is applicable in IHC, IF, FC

Monoclonal CD34 (Hematopoietic Stem Cell & Endothelial Marker) Antibody, Clone: SPM610

AMM01557G 7 ml
EUR 580.8
Description: A Monoclonal antibody against Human CD34 (Hematopoietic Stem Cell & Endothelial Marker). The antibodies are raised in Mouse and are from clone SPM610. This antibody is applicable in WB, IHC and IF, FC

Rat Bone Marrow PrimaCell: Hematopoietic Cells

2-82590 1 Kit Ask for price

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF594 conjugate, 0.1mg/mL

BNC942598-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF594 conjugate, 0.1mg/mL

BNC942598-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), CF568 conjugate, 0.1mg/mL

BNC682184-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), CF568 conjugate, 0.1mg/mL

BNC682184-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF568 conjugate, 0.1mg/mL

BNC682185-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF568 conjugate, 0.1mg/mL

BNC682185-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF568 conjugate, 0.1mg/mL

BNC682598-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF568 conjugate, 0.1mg/mL

BNC682598-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), CF647 conjugate, 0.1mg/mL

BNC472184-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), CF647 conjugate, 0.1mg/mL

BNC472184-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF647 conjugate, 0.1mg/mL

BNC472185-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF647 conjugate, 0.1mg/mL

BNC472185-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF647 conjugate, 0.1mg/mL

BNC472598-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF647 conjugate, 0.1mg/mL

BNC472598-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), CF594 conjugate, 0.1mg/mL

BNC942184-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), CF594 conjugate, 0.1mg/mL

BNC942184-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF594 conjugate, 0.1mg/mL

BNC942185-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF594 conjugate, 0.1mg/mL

BNC942185-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), CF488A conjugate, 0.1mg/mL

BNC882184-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), CF488A conjugate, 0.1mg/mL

BNC882184-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF488A conjugate, 0.1mg/mL

BNC882185-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF488A conjugate, 0.1mg/mL

BNC882185-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF488A conjugate, 0.1mg/mL

BNC882598-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF488A conjugate, 0.1mg/mL

BNC882598-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF640R conjugate, 0.1mg/mL

BNC402598-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF640R conjugate, 0.1mg/mL

BNC402598-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), CF405S conjugate, 0.1mg/mL

BNC042184-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), CF405S conjugate, 0.1mg/mL

BNC042184-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF405S conjugate, 0.1mg/mL

BNC042185-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF405S conjugate, 0.1mg/mL

BNC042185-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF405S conjugate, 0.1mg/mL

BNC042598-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), CF405S conjugate, 0.1mg/mL

BNC042598-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), CF640R conjugate, 0.1mg/mL

BNC402184-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), CF640R conjugate, 0.1mg/mL

BNC402184-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF640R conjugate, 0.1mg/mL

BNC402185-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), CF640R conjugate, 0.1mg/mL

BNC402185-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), Biotin conjugate, 0.1mg/mL

BNCB2184-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker)(PODXL/2184), Biotin conjugate, 0.1mg/mL

BNCB2184-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), Biotin conjugate, 0.1mg/mL

BNCB2185-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker) (PODXL/2185), Biotin conjugate, 0.1mg/mL

BNCB2185-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD34 (Hematopoietic Stem Cell & Endothelial Marker) (HPCA1/2598R), Biotin conjugate, 0.1mg/mL

BNCB2598-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

UFPs have been discovered to change in vitro and in vivo responses of the immune system to allergens and may also play a task in allergen sensitization. The inflammatory properties of UFPs may be mediated by a quantity of totally different mechanisms, together with the power to provide reactive oxygen species, resulting in the era of proinflammatory cytokines and airway irritation.

In addition, as a result of of their small measurement, UFPs even have distinctive distribution traits in the respiratory tree and circulation and would possibly be capable of alter mobile perform in ways in which circumvent regular signaling pathways.

Additionally, UFPs can penetrate intracellularly and probably trigger DNA injury. The current advances in nanotechnology, though opening up new alternatives for the development of expertise and medication, may additionally result in unexpected hostile well being results in uncovered human topics.

Further analysis is required to make clear the protection of nanoscale particles, in addition to the elucidation of the doable helpful use of these particulates to deal with illness.

Leave a Comment